Novogene Co., Ltd. (SHA:688315)
China · Delayed Price · Currency is CNY 19.39
+0.37 (1.95%)
Sep 23, 2026, 3:00 PM CST
Novogene Market Cap
Novogene has a market cap or net worth of 7.87 billion as of September 23, 2026. Its market cap has increased by 26.15% in one year.
Market Cap
7.87B
Enterprise Value
6.24B
Revenue
2.28B
Ranking
n/a
PE Ratio
51.03
Stock Price
19.39
ChartMarket Cap Chart
Since April 13, 2021, Novogene's market cap has decreased from 10.97B to 7.87B, a decrease of -28.19%. That is a compound annual growth rate of -5.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 7.85B | 46.01% |
| Dec 31, 2025 | 5.38B | 6.24% |
| Dec 31, 2024 | 5.06B | -47.88% |
| Dec 29, 2023 | 9.71B | -8.02% |
| Dec 30, 2022 | 10.56B | -36.10% |
| Dec 31, 2021 | 16.53B | 50.73% |
| Apr 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bio-Thera Solutions | 8.81B |
| Vcanbio Cell & Gene Engineering Corp., | 8.79B |
| Liaoning Chengda Biotechnology | 8.59B |
| Novoprotein Scientific | 8.54B |
| Beijing Hotgen Biotech | 8.42B |
| Aurisco Pharmaceutical | 8.05B |
| Daan Gene | 7.86B |
| Innovita Biological Technology | 7.79B |